Monday, January 02, 2023 8:03:38 PM
All of us in the medical community want to see surgery improve, outcomes get better, adverse incidents go down. The problem with Titan is that the Enos doesn't deliver any of that - at least not any better than existing alternatives. The Enos doesn't even work or have the right software engineering to operate in tandem with other OR equipment.
There's been a revolving door of surgeon advisors who've trialed the system and then faded off into the ether. The best anyone can say about the Enos is that it has a good camera and light - that was Estape. No doubt the medical community feels as misled about Titan as do the investors. Wouldn't you think if all the docs and hospitals involved with the Enos development loved it, they'd be buying the stock, talking it up with their friends, and the buzz building?
I ultimately hope the engineers who lost their jobs didn't commit their careers to Titan in vain - that some of the IP hopefully can be used by whomever ends up taking it in future designs of other devices. Problem is the IP is only valuable with the people themselves as MDT took the patents of any intrinsic value ... and now the people are gone.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM